

Drug Class: Mitochondrial-Derived Peptide (MDP)
Composition: Mitochondrial Open Reading Frame of the 12S rRNA-c
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Injectable Use After Reconstitution
Dragon Pharma MOTS-C 10 mg represents a groundbreaking advancement in peptide therapy, targeting the very core of cellular energy and metabolism. MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a unique, mitochondria-derived peptide that acts as a powerful regulator of metabolic homeostasis. Unlike nuclear DNA-encoded peptides, MOTS-C is encoded within the mitochondrial genome and released in response to metabolic stress, such as exercise and caloric restriction. This 10 mg vial of pure, lyophilized peptide provides a potent dose to harness these innate protective mechanisms. MOTS-C works by optimizing the balance between glucose and fatty acid metabolism, enhancing insulin sensitivity, and promoting cellular resilience. For bodybuilders, athletes, and longevity enthusiasts, MOTS-C offers a sophisticated approach to improving body composition, boosting exercise performance, and supporting healthy aging from the cellular level upward.
MOTS-C operates through a unique mechanism that mimics the beneficial effects of exercise and fasting at a molecular level. Its primary action involves the activation of the AMPK pathway (AMP-activated protein kinase), a key cellular energy sensor. This activation shifts the body's metabolism towards more efficient energy utilization, leading to enhanced insulin sensitivity and improved glucose uptake into muscles, which is crucial for both performance and fat loss. One of the most significant benefits is the prevention of age-dependent and diet-induced insulin resistance, making it easier to maintain a lean physique. MOTS-C also promotes fatty acid oxidation, encouraging the body to use stored fat for energy. Beyond metabolism, it enhances physical performance by increasing endurance and exercise capacity, likely through improved mitochondrial efficiency and reduced fatigue. Furthermore, MOTS-C has demonstrated neuroprotective effects and may support cognitive health. For those seeking to combat the metabolic slowdown that can occur with age or during extensive cutting phases, MOTS-C provides a powerful, systemic solution. The pioneering research on MOTS-c has highlighted its critical role in metabolic regulation, showing its ability to reverse diet-induced obesity and insulin resistance in animal models.
Dragon Pharma MOTS-C 10 mg is supplied as a lyophilized powder that must be reconstituted with Bacteriostatic Water before use. As a relatively new peptide, dosing protocols are still being refined, but established ranges have shown efficacy.
Reconstitution: Inject 1-2 mL of Bacteriostatic Water into the vial. Gently swirl until the powder is completely dissolved; do not shake. Store the reconstituted solution in the refrigerator.
Common Dosing Protocol: MOTS-C has a relatively long half-life, allowing for less frequent dosing compared to many other peptides. A common and effective protocol involves administering 5-10 mg, 2-3 times per week. This means one 10 mg vial provides 1-2 doses. Injections are typically performed subcutaneously (SubQ). Some users prefer to administer doses on non-consecutive days (e.g., Monday, Wednesday, Friday). For a more aggressive approach, particularly for addressing significant insulin resistance or during a intense cutting phase, doses of 5 mg every other day can be used. Cycles typically last 6-12 weeks, followed by a break of equal length.
MOTS-C is a versatile foundational peptide that excels in various stacks, particularly those focused on metabolic health, endurance, and longevity.
MOTS-C is considered to have an excellent safety profile, largely because it mimics a naturally occurring signaling molecule that the body produces under healthy conditions like exercise.
The exceptional tolerability of MOTS-C makes it suitable for long-term use and for individuals who are sensitive to the side effects of other performance-enhancing or metabolic compounds.
Name: Mitochondrial Open Reading Frame of the 12S rRNA-c
Drug Class: Mitochondrial-Derived Peptide (MDP)
Other common names and terms: MOTS-c, Mitochondrial Peptide
Active Life: Several days
Detection Time: Approximately 1 week
Chemical Structure: 16-amino acid peptide (MRWQEMGYIFYPRKLR)
Common Doses: 5-10 mg, 2-3 times per week
Blood pressure: No significant effect; may support healthy blood pressure
Acne: No
Water retention: No
Aromatisation: No
Liver toxicity: None
Decrease HPTA function: No
MOTS-C and AOD9604 both affect metabolism but through entirely different mechanisms. AOD9604 is a modified fragment of Growth Hormone that works on fat cells to promote lipolysis (fat breakdown). MOTS-C is encoded in mitochondrial DNA and works systemically by activating the AMPK pathway, which improves insulin sensitivity, enhances glucose uptake into muscles, and boosts mitochondrial efficiency. Think of AOD9604 as a targeted fat-burner, while MOTS-C is a comprehensive metabolic optimizer.
Yes. While its effects are most pronounced in individuals with metabolic issues, MOTS-C can benefit anyone by enhancing metabolic efficiency. By promoting fatty acid oxidation and improving how your body uses energy, it can help create a more favorable environment for fat loss, even in metabolically healthy individuals. Its ability to boost endurance also means you can train harder and longer, further contributing to a calorie deficit.
Absolutely. MOTS-C is an excellent choice for women. Its clean, non-hormonal mechanism of action and lack of androgenic side effects make it very well-tolerated. The benefits of improved metabolism, enhanced endurance, and support for healthy aging are highly sought after by female athletes and those focused on wellness. Women can use the same dosing protocols as men.
While MOTS-C is very safe, cycling is still recommended to prevent potential receptor desensitization and to allow the body to maintain its natural regulatory balance. A common protocol is to use MOTS-C for 6-12 weeks, followed by a break of 4-8 weeks. This pattern allows for sustained benefits over the long term.
The effects of MOTS-C are cumulative and systemic. Some users report a subtle increase in energy and endurance within the first 1-2 weeks. The more significant metabolic benefits, such as improved body composition and insulin sensitivity, typically become noticeable after 4-6 weeks of consistent use. For longevity and cellular health benefits, long-term use is most effective.
Please log in to write MOTS-C 10 mg review.
Drug Class: Recombinant Human Growth Hormone (rHGH)
Composition: Somatropin 191aa
Dosage: 10 IU/vial
Form: Lyophilized Powder
Unit: 1 Kit (10 x 2 mL Vials)
Brand: Dragon Pharma
Laboratory Test: View Latest Lab Report
For Injectable Use After Reconstitution
Drug Class: Gonadotropin, Fertility Agent
Composition: Human Chorionic Gonadotropin (HCG)
Dosage: 2500 IU/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Synthetic Peptide (Thymosin Beta-4)
Composition: Thymosin Beta-4
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Gonadotropin, Fertility Agent, LH Analog
Composition: Human Chorionic Gonadotropin
Dosage: 5000 IUs/vial
Form: Lyophilized Powder
Unit: 2 mL Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection